Aiping Shi

638 total citations
37 papers, 451 citations indexed

About

Aiping Shi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Aiping Shi has authored 37 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Aiping Shi's work include Cancer Cells and Metastasis (9 papers), Breast Cancer Treatment Studies (6 papers) and Breast Lesions and Carcinomas (5 papers). Aiping Shi is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Breast Cancer Treatment Studies (6 papers) and Breast Lesions and Carcinomas (5 papers). Aiping Shi collaborates with scholars based in China, United States and Japan. Aiping Shi's co-authors include Zhimin Fan, Ye Du, Gang Zhao, Zhimin Fan, Bing Han, Zhiru Zhang, Dong Eun Song, Dongxu Liu, Le Ma and Zhenyu Liu and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Oncogene.

In The Last Decade

Aiping Shi

34 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aiping Shi China 14 207 146 110 43 39 37 451
Darko Castven Germany 10 229 1.1× 106 0.7× 114 1.0× 43 1.0× 43 1.1× 22 425
Luoqi Jia China 9 282 1.4× 123 0.8× 120 1.1× 47 1.1× 29 0.7× 13 452
Jessica Plati United States 6 354 1.7× 112 0.8× 102 0.9× 47 1.1× 32 0.8× 8 521
Siriporn Keeratichamroen Thailand 13 268 1.3× 119 0.8× 89 0.8× 59 1.4× 44 1.1× 23 492
Shafquat Azim United States 12 275 1.3× 153 1.0× 126 1.1× 42 1.0× 52 1.3× 25 554
Prathap Kumar S. Mahalingaiah United States 12 314 1.5× 218 1.5× 84 0.8× 43 1.0× 35 0.9× 20 647
Kamila Balušíková Czechia 14 187 0.9× 104 0.7× 62 0.6× 35 0.8× 31 0.8× 20 462
Yougen Wu China 12 302 1.5× 120 0.8× 133 1.2× 23 0.5× 52 1.3× 24 573
Nianping Chen China 12 284 1.4× 79 0.5× 96 0.9× 54 1.3× 42 1.1× 18 457
Yong‐Tark Jeon South Korea 9 225 1.1× 109 0.7× 138 1.3× 35 0.8× 49 1.3× 16 431

Countries citing papers authored by Aiping Shi

Since Specialization
Citations

This map shows the geographic impact of Aiping Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiping Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiping Shi more than expected).

Fields of papers citing papers by Aiping Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiping Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiping Shi. The network helps show where Aiping Shi may publish in the future.

Co-authorship network of co-authors of Aiping Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Aiping Shi. A scholar is included among the top collaborators of Aiping Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiping Shi. Aiping Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Aiping, Yixin Shi, Xuebin Ma, et al.. (2025). Advancements in 3D gel culture systems for enhanced angiogenesis in bone tissue engineering. Journal of Materials Chemistry B. 13(11). 3516–3527. 1 indexed citations
2.
Zhang, Yuheng, Aiping Shi, Xibo Pei, et al.. (2025). Optimized fabrication of L-Asp-Cu(II) Bio-MOF for enhanced vascularized bone regeneration. Chemical Engineering Journal. 505. 159617–159617. 10 indexed citations
3.
4.
5.
Yuan, Bo, Jinquan Liu, Aiping Shi, et al.. (2023). HERC3 promotes YAP / TAZ stability and tumorigenesis independently of its ubiquitin ligase activity. The EMBO Journal. 42(4). e111549–e111549. 19 indexed citations
6.
Lin, Meng, Amy T. Ku, Jie Dong, et al.. (2022). STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential. Oncogene. 41(48). 5214–5222. 5 indexed citations
7.
Liu, Hui, et al.. (2021). Giant Fungated Locally Advanced Breast Carcinoma Responded to Hypofractionated Radiotherapy Combined with Apatinib: A Case Report and Literature Review. Cancer Management and Research. Volume 13. 605–611. 4 indexed citations
8.
Zhang, Yu, Di Wu, Bo Zhao, et al.. (2021). Application of neoadjuvant chemotherapy combined with anlotinib in occult breast cancer: A case report and review of literature. World Journal of Clinical Cases. 9(4). 919–926. 3 indexed citations
9.
Jin, Ying, Wenquan Hu, Tong Liu, et al.. (2018). Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel. Cancer Letters. 419. 233–244. 15 indexed citations
10.
Gao, Pin, Xiang Wang, Ying Jin, et al.. (2018). Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells. Breast Cancer Research. 20(1). 112–112. 11 indexed citations
11.
Shi, Aiping, Zhimin Fan, Kewei Ma, et al.. (2017). Isolation and characterization of adult mammary stem cells from breast cancer-adjacent tissues. Oncology Letters. 14(3). 2894–2902. 8 indexed citations
12.
Zhu, Zhu, Ling Li, Zhong Ye, et al.. (2017). Prognostic value of routine laboratory variables in prediction of breast cancer recurrence. Scientific Reports. 7(1). 8135–8135. 13 indexed citations
13.
Dong, Jie, et al.. (2015). The PR status of the originating cell of ER/PR-negative mouse mammary tumors. Oncogene. 35(31). 4149–4154. 4 indexed citations
14.
Xu, Ning, et al.. (2015). Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer. Cancer Epidemiology. 39(3). 375–381. 16 indexed citations
15.
Du, Ye, Aiping Shi, Bing Han, et al.. (2014). COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro. International Journal of Oncology. 44(4). 1385–1393. 9 indexed citations
16.
Li, Junqing, et al.. (2013). Species diversity of epiphytic bryophytes in Baihua Mountain National Nature Reserve, Beijing. 32(4). 838–844. 1 indexed citations
17.
Shi, Aiping, Di Wu, Xingliang Li, et al.. (2012). Subcutaneous Nipple-Sparing Mastectomy and Immediate Breast Reconstruction. Breast Care. 7(2). 131–136. 14 indexed citations
18.
Xu, Ning, et al.. (2012). Renal Primitive Malignant Tumor with Endocrine Activity. Medical Principles and Practice. 22(2). 200–203. 1 indexed citations
19.
Shi, Aiping, Sijie Li, Ning Xu, et al.. (2010). Clinical Features and Prognosis of a Unilateral Fibroadenoma of the Breast in a 16-Month-Old Female. Japanese Journal of Clinical Oncology. 41(2). 260–264. 4 indexed citations
20.
Wang, Lingling, Hiroko Hisha, Tetsuya Mizokami, et al.. (2009). Mouse mesenchymal stem cells can support human hematopoiesis both in vitro and in vivo: the crucial role of neural cell adhesion molecule. Haematologica. 95(6). 884–891. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Darko Castven Breakdown of academic impact, for papers by Luoqi Jia Breakdown of academic impact, for papers by Jessica Plati Breakdown of academic impact, for papers by Siriporn Keeratichamroen Breakdown of academic impact, for papers by Shafquat Azim Breakdown of academic impact, for papers by Prathap Kumar S. Mahalingaiah Breakdown of academic impact, for papers by Kamila Balušíková Breakdown of academic impact, for papers by Yougen Wu Breakdown of academic impact, for papers by Nianping Chen Breakdown of academic impact, for papers by Yong‐Tark Jeon
Rankless by CCL
2026